Provided by Tiger Trade Technology Pte. Ltd.

NovaBay Pharmaceuticals

0.6012
+0.091217.88%
Post-market: 0.5850-0.0162-2.69%19:50 EST
Volume:7.96M
Turnover:5.14M
Market Cap:78.16M
PE:1.29
High:0.7500
Open:0.5600
Low:0.5063
Close:0.5100
52wk High:19.95
52wk Low:0.4342
Shares:130.00M
Float Shares:4.98M
Volume Ratio:4.38
T/O Rate:159.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4666
EPS(LYR):-2.5347
ROE:-516.26%
ROA:-86.98%
PB:-29.13
PE(LYR):-0.24

Loading ...

NovaBay Pharmaceuticals Announces 1-for-5 Reverse Stock Split

Reuters
·
Feb 12

NovaBay Pharmaceuticals Inc. Announces Date for Upcoming Special Meeting of Stockholders

Reuters
·
Jan 31

Amex Halt Add Info Lst 2.110000

THOMSON REUTERS
·
Jan 28

Small U.S. Stocks Decrease; NovaBay Pharmaceuticals Posts Biggest Loss

Dow Jones
·
Jan 21

Top Midday Decliners

MT Newswires Live
·
Jan 21

NovaBay Pharmaceuticals Reports At-The-Market Equity Program

MT Newswires Live
·
Jan 21

NovaBay trading halted, volatility trading pause

TIPRANKS
·
Jan 20

Amex Halt Add Info Lst 9.690000

THOMSON REUTERS
·
Jan 20

NovaBay Pharmaceuticals Inc - Files for Offering of up to $100 Mln Common Stock - SEC Filing

THOMSON REUTERS
·
Jan 20

Assessing NovaBay Pharmaceuticals (NBY) Valuation After Digital Asset Financing And SKY Token Treasury Shift

Simply Wall St.
·
Jan 19

NovaBay falls -17.1%

TIPRANKS
·
Jan 13

Amex Halt Add Info Lst 10.690000

THOMSON REUTERS
·
Jan 13

Small U.S. Stocks Move Upward; NovaBay Pharmaceuticals Climbs Highest

Dow Jones
·
Jan 10

NovaBay Pharmaceuticals Reports Turnaround in Earnings

TIPRANKS
·
Nov 14, 2025

NovaBay Pharmaceuticals Inc. Files Initial Beneficial Ownership Statement for CEO and Director Michael Kazley

Reuters
·
Oct 21, 2025

NovaBay Pharmaceuticals, Inc. Regains Compliance With Nyse American Continued Listing Standards

THOMSON REUTERS
·
Oct 21, 2025

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

GlobeNewswire
·
Oct 21, 2025

NovaBay Pharmaceuticals - on Oct 16, Michael Kazley Appointed as CEO and Chairman - SEC Filing

THOMSON REUTERS
·
Oct 20, 2025

NovaBay Pharmaceuticals Sells Preferred Shares and Pre-Funded Warrants Totaling $18 Million

Reuters
·
Oct 20, 2025

NovaBay Pharmaceuticals Inc - David Lazar Resigns as CEO - SEC Filing

THOMSON REUTERS
·
Oct 10, 2025